| # | Drug | Count |
|---|---|---|
| 0 | ALBUTEROL SULFATE | 1 |
| 1 | AMBRISENTAN | 1 |
| 2 | ATENOLOL | 1 |
| 3 | BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE | 1 |
| 4 | FINASTERIDE | 1 |
| 5 | FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE | 1 |
| 6 | FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE | 1 |
| 7 | INSULIN ASPART | 1 |
| 8 | INSULIN GLARGINE AND LIXISENATIDE | 1 |
| 9 | LISINOPRIL | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PALTUSOTINE | 1 | 0.0042 |
| 1 | INSULIN GLARGINE AND LIXISENATIDE | 1 | 0.0003 |
| 2 | TIOTROPIUM BROMIDE INHALATION SPRAY | 1 | 0.0001 |
| 3 | PRAVASTATIN SODIUM | 1 | 0.0000 |
| 4 | FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE | 1 | 0.0000 |
| 5 | NITROGLYCERIN | 1 | 0.0000 |
| 6 | FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE | 1 | 0.0000 |
| 7 | FINASTERIDE | 1 | 0.0000 |
| 8 | INSULIN ASPART | 1 | 0.0000 |
| 9 | BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE | 1 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | 5-alpha Reductase Inhibitor [EPC] | 1 |
| 1 | Corticosteroid [EPC] | 1 |
| 2 | Endothelin Receptor Antagonist [EPC] | 1 |
| 3 | GLP-1 Receptor Agonist [EPC] | 1 |
| 4 | Insulin Analog [EPC] | 1 |
| 5 | Nitrate Vasodilator [EPC] | 1 |
| 6 | Phosphodiesterase 5 Inhibitor [EPC] | 1 |
| 7 | beta-Adrenergic Blocker [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Nitrate Vasodilator [EPC] | 1 | 0.0000 |
| 1 | 5-alpha Reductase Inhibitor [EPC] | 1 | 0.0000 |
| 2 | Phosphodiesterase 5 Inhibitor [EPC] | 1 | 0.0000 |
| 3 | Endothelin Receptor Antagonist [EPC] | 1 | 0.0000 |
| 4 | beta-Adrenergic Blocker [EPC] | 1 | 0.0000 |
| 5 | GLP-1 Receptor Agonist [EPC] | 1 | 0.0000 |
| 6 | Insulin Analog [EPC] | 1 | 0.0000 |
| 7 | Corticosteroid [EPC] | 1 | 0.0000 |